These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 10836299)
1. Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors. Roger P; Daures JP; Maudelonde T; Pignodel C; Gleizes M; Chapelle J; Marty-Double C; Baldet P; Mares P; Laffargue F; Rochefort H Hum Pathol; 2000 May; 31(5):593-600. PubMed ID: 10836299 [TBL] [Abstract][Full Text] [Related]
2. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Roger P; Sahla ME; Mäkelä S; Gustafsson JA; Baldet P; Rochefort H Cancer Res; 2001 Mar; 61(6):2537-41. PubMed ID: 11289127 [TBL] [Abstract][Full Text] [Related]
3. Increased estrogen receptor betacx expression during mammary carcinogenesis. Esslimani-Sahla M; Kramar A; Simony-Lafontaine J; Warner M; Gustafsson JA; Rochefort H Clin Cancer Res; 2005 May; 11(9):3170-4. PubMed ID: 15867209 [TBL] [Abstract][Full Text] [Related]
4. Is there a low-grade precursor pathway in breast cancer? King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747 [TBL] [Abstract][Full Text] [Related]
5. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues. Bozkurt KK; Kapucuoğlu N Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175 [TBL] [Abstract][Full Text] [Related]
7. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast. Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Sasano H Jpn J Cancer Res; 2000 Nov; 91(11):1169-76. PubMed ID: 11092983 [TBL] [Abstract][Full Text] [Related]
9. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Abdel-Fatah TM; Powe DG; Hodi Z; Lee AH; Reis-Filho JS; Ellis IO Am J Surg Pathol; 2007 Mar; 31(3):417-26. PubMed ID: 17325484 [TBL] [Abstract][Full Text] [Related]
10. Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas. Greco S; Marsigliante S; Leo G; Storelli C Cancer Lett; 2000 Nov; 160(1):13-9. PubMed ID: 11098079 [TBL] [Abstract][Full Text] [Related]
11. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Rudas M; Neumayer R; Gnant MF; Mittelböck M; Jakesz R; Reiner A Eur J Cancer; 1997 Jan; 33(1):39-44. PubMed ID: 9071897 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Järvinen TA; Pelto-Huikko M; Holli K; Isola J Am J Pathol; 2000 Jan; 156(1):29-35. PubMed ID: 10623650 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer. Huang B; Omoto Y; Iwase H; Yamashita H; Toyama T; Coombes RC; Filipovic A; Warner M; Gustafsson JÅ Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1933-8. PubMed ID: 24449868 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor β2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions. Chantzi NI; Palaiologou M; Stylianidou A; Goutas N; Vassilaros S; Kourea HP; Dhimolea E; Mitsiou DJ; Tiniakos DG; Alexis MN J Cancer Res Clin Oncol; 2014 Jun; 140(6):1057-66. PubMed ID: 24671226 [TBL] [Abstract][Full Text] [Related]
15. [Expression of Fascin-1 protein in breast cancer and its clinicopathologic correlation]. Wang C; Huang B; Wu Z; Sun X; Zeng Y; Wang Y Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):451-4. PubMed ID: 25327793 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis. Esslimani-Sahla M; Thezenas S; Simony-Lafontaine J; Kramar A; Lavaill R; Chalbos D; Rochefort H Int J Cancer; 2007 Jan; 120(2):224-9. PubMed ID: 17044016 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions. Burrai GP; Mohammed SI; Miller MA; Marras V; Pirino S; Addis MF; Uzzau S; Antuofermo E BMC Cancer; 2010 Apr; 10():156. PubMed ID: 20412586 [TBL] [Abstract][Full Text] [Related]
18. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up. Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573 [TBL] [Abstract][Full Text] [Related]
19. Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions. Tsuda H; Hirohashi S Pathol Int; 1998 Jul; 48(7):518-25. PubMed ID: 9701014 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical visualisation of cathepsin-D expression in breast cancer. Barthell E; Mylonas I; Shabani N; Kunze S; Kuhn C; Jeschke U; Friese K Anticancer Res; 2007; 27(4A):2035-9. PubMed ID: 17649818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]